Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice. - Wikidata - awgldk - TriplyDB

Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

http://www.wikidata.org/entity/Q35141469

about

Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma Genetics and biology of pancreatic ductal adenocarcinoma Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies Myeloid suppressor cells and immune modulation in lung cancer Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer.The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.Tumor regression is mediated via the induction of HER263-71- specific CD8+ CTL activity in a 4T1.2/HER2 tumor model: no involvement of CD80 in tumor control.The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells.Expansion of myeloid-derived suppressor cells from peripheral blood decreases after 4-week antiviral treatment in patients with chronic hepatitis C.Anti-hepatocarcinoma activity of TT-1, an analog of melittin, combined with interferon-α via promoting the interaction of NKG2D and MICA Interferons and their stimulated genes in the tumor microenvironment The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors Gangliosides drive the tumor infiltration and function of myeloid-derived suppressor cells.Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice.The NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription.Dendritic cell-activating vaccine adjuvants differ in the ability to elicit antitumor immunity due to an adjuvant-specific induction of immunosuppressive cells.Myeloid Suppressor Cells Accumulate and Regulate Blood Pressure in Hypertension.Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks.The homing receptor CD44 is involved in the progression of precancerous gastric lesions in patients infected with Helicobacter pylori and in development of mucous metaplasia in mice.PcpA Promotes Higher Levels of Infection and Modulates Recruitment of Myeloid-Derived Suppressor Cells during Pneumococcal Pneumonia.NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by Cytokines Re-polarizing Myeloid-derived Suppressor Cells (MDSCs) with Cationic Polymers for Cancer Immunotherapy.Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment.Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells.Natural killer cells require monocytic Gr-1(+)/CD11b(+) myeloid cells to eradicate orthotopically engrafted glioma cells Myeloid-derived suppressor cells in breast cancer.Deficiency of Kruppel-like factor KLF4 in mammary tumor cells inhibits tumor growth and pulmonary metastasis and is accompanied by compromised recruitment of myeloid-derived suppressor cells Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways.Immunological off-target effects of standard treatments in gastrointestinal cancers Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes.In vivo immune cell distribution of gold nanoparticles in naïve and tumor bearing mice.Ceramide activates lysosomal cathepsin B and cathepsin D to attenuate autophagy and induces ER stress to suppress myeloid-derived suppressor cells.Role of myeloid-derived suppressor cells in tumor immunotherapy.Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives.

P2860

Q26753070-B90D46D6-DB1C-430F-94E7-AB9F8841CB53 Q26765438-24BB4C3F-2767-49FE-AC0A-DB4ACB052B07 Q26781215-B5DD92F0-C4A9-402E-B792-5CC02F3A4819 Q26823251-3C8CC640-070D-40E3-B0BC-F941E10D0A3F Q26863418-EA3BD78C-185F-42CA-89DA-3AE6AEF8313A Q28393381-91BCF4D6-8CD4-4F83-BABA-152A89775E37 Q28486600-540D16DF-05D9-4F3E-BFFB-0D74FD377D34 Q30413623-7A34A2A0-C81C-403F-94DD-785037112E2B Q33606107-3936DDAC-60BE-43AA-9158-982962AA2B50 Q33660069-7FD23A10-FACD-4B31-8D81-B0677B585253 Q33688821-35526D8A-BACD-4E1D-AB06-514FDAAD0583 Q33709243-75870DCA-3104-476E-8AD2-404544BC2BEC Q33756291-43CD124D-ECC4-4D1C-9B6F-49E63A99F672 Q33825926-386169C2-741D-4347-B60F-4FA6DD89FA89 Q33988567-5681CFE2-4209-41B1-879D-725019E4E48B Q34228171-3BBDE205-5880-4D26-8B47-2E12DAF70ED0 Q34288047-C50985F3-FA50-4BFD-82EA-49F4733AD004 Q35506478-1C9AD6A2-2D3B-4FEC-8AB4-926217D8CAAD Q35819880-FDA3C930-DEF7-466C-91C6-134C9872D7A5 Q36007456-C363602D-0800-4741-BD13-7C9B1D9CFB50 Q36202604-76B182B2-6089-4411-94C1-948E4B6F80A8 Q36272860-F5702CF8-4ECE-4BDC-BEBF-119C26213917 Q36390700-5B7112F9-34D4-4170-9F5B-A4BE610C6ADF Q36467210-EE3008FE-8E62-4F49-AA8F-CD14EE68CCE6 Q36600946-F3D06EAF-99BA-424B-A60A-DCD62840183D Q36759187-69B89E8E-A8C4-4EEC-AB85-A35712392121 Q36796146-55F12145-B155-42E1-BF56-D8EFAC340ECC Q36918248-42792B08-B86F-47BE-A0AD-2E887BBEAAAA Q36967364-89766ABD-228B-453A-AB40-D1B73FD0A80D Q37031596-8AFFA1F8-7E62-4A4D-8C0B-025C02653947 Q37079098-845FF188-572A-4AD1-8007-6942D9FF7DC8 Q37172813-B21404D9-0416-4F7C-9F71-B515DA3D7280 Q37228480-017F07D6-4521-4D46-A1F1-38D92A780DEC Q37371697-0DF1F90C-B0CC-4F98-AB83-3F2796A992B2 Q37404086-DA4C3F02-921D-4A7D-96CF-85E100394DB7 Q37544847-F0A4302A-402B-4446-BFB6-50635CE69255 Q37656558-3370A281-C300-4935-ADCF-A83509BF4233 Q37708912-AC492B59-A081-4D31-838C-EF46C53F75E7 Q37965750-31E8CE10-62DE-4284-BB67-81BC7723EAE6 Q38047050-CD1D6FC2-B245-4FCE-8AE7-61C414D54331

P2860

Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

http://www.wikidata.org/entity/Q35141469

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

@ast

Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

@en

type

label

Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

@ast

Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

@en

prefLabel

Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

@ast

Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

@en

P1433

Q35141469-992A4FBC-6586-475C-AB2C-6CCFEF79942C

P1476

Q35141469-2F994589-E07A-4346-BEDB-8A00FAFFE4FB

P2093

Q35141469-0A19E8C6-2E73-4346-A11D-BF40A710186C

Q35141469-1935A8AD-79E7-487C-AA5E-634FDA11B81F

Q35141469-224C6EDE-0A75-4178-B689-BD1AD63E6052

Q35141469-48B6878F-154D-4812-985D-BAEB4474CCAC

Q35141469-5C82AFDA-F33A-47BE-95CB-47452CFF278D

Q35141469-676F65D3-91D2-4879-928C-FB1A58D65DC8

Q35141469-78778D72-9AAE-4A0D-9F46-0BE4F6297E62

Q35141469-888317B0-6CE2-41F0-9EE3-DE11AD4F254B

Q35141469-99EBCB14-3338-4B29-9625-7A1C82E67421

Q35141469-C1236336-9C61-4B02-B3DD-F3B25C8BE98A

P2860

Q35141469-0B12F713-E192-4823-96B3-D98A1193AEA9

Q35141469-1387AB27-DEF6-4277-88FB-D9387E4548AD

Q35141469-1685BC13-9096-4539-94CC-6E121E393278

Q35141469-16D097F3-2FD9-48D5-9D6F-6A5D8202A6A4

Q35141469-323C37CB-C0D3-43B8-9C71-1E22508E70D4

Q35141469-33EBA5A7-5816-4BC3-9D53-A82812871112

Q35141469-3437E453-198C-4691-9915-62B3FB8E24C7

Q35141469-347DCEF7-0F8F-4912-8C8B-2FC47126E6E3

Q35141469-404B8DAE-037B-451E-818F-24E1854D7874

Q35141469-4B19C58E-F46D-47BD-8398-0675DC635236

P304

Q35141469-4CE25A6D-6A20-4E4A-8983-ED6DA891A6B8

P31

Q35141469-DA003A73-74F0-49B1-8822-EB77A069006E

P356

Q35141469-E6FF74DA-B1AC-42FA-9D52-23B1DD2E1C7C

P407

Q35141469-81520A02-BDA5-40A8-9FC8-7700E8DA2AB7

P433

Q35141469-0EC821F7-331F-4EE0-B2B8-E6E10BF53262

P478

Q35141469-762C214D-20F8-4590-8AAD-C28280F7B855

P50

Q35141469-B4DE8725-D143-4E0C-B20A-29F61AAEAA64

P577

Q35141469-A8AA677A-B610-491C-ACFF-868DFC7A3EA2

P698

Q35141469-7E64D6F6-A3C5-4AB3-9E02-E10863BCA746

P932

Q35141469-A66C942E-ACBC-4D20-932C-01CFF8B3F1F3

P356

0008-5472.CAN-10-2670

P1433

Cancer Research

P1476

Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice

@en

P2093

Abhik Ray Chaudhury

http://www.w3.org/2001/XMLSchema#string

Alena C Jaime-Ramirez

http://www.w3.org/2001/XMLSchema#string

Bethany L Mundy-Bosse

http://www.w3.org/2001/XMLSchema#string

Denis C Guttridge

http://www.w3.org/2001/XMLSchema#string

Gregory B Lesinski

http://www.w3.org/2001/XMLSchema#string

Gregory Young

http://www.w3.org/2001/XMLSchema#string

Krista M La Perle

http://www.w3.org/2001/XMLSchema#string

Kristan Guenterberg

http://www.w3.org/2001/XMLSchema#string

Kristen Benninger

http://www.w3.org/2001/XMLSchema#string

Melanie Kreiner

http://www.w3.org/2001/XMLSchema#string

P2860

Myeloid-derived suppressor cells: linking inflammation and cancer

Myeloid-derived suppressor cells as regulators of the immune system

Cancer immunoediting: from immunosurveillance to tumor escape

Interferons, immunity and cancer immunoediting

Impaired response to interferon-gamma in activated macrophages due to tyrosine nitration of STAT1 by endogenous nitric oxide

Regulation of immune responses by L-arginine metabolism

Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.

Modulators of arginine metabolism support cancer immunosurveillance.

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.

Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.

P304

5101-5110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-2670

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21680779

http://www.w3.org/2001/XMLSchema#string

P932

3148319

http://www.w3.org/2001/XMLSchema#string